EU Health Product Manufacturers Call for Guidance on Flexibility of Claims Wording

09 Feb 2012 --- Welcoming the European Commission’s decision to allow the food sector some flexibility when making claims, EHPM said that because of concerns that the average consumer will not understand some of the scientific terminology, claims should be accompanied by further explanatory details.

Feb 9 2012 --- Guidance on the acceptability of flexible wordings when communicating article 13.1 health claims to consumers will be valuable for both enforcement bodies and companies, the European Federation of Associations of Health Product Manufacturers (EHPM) has said.

Welcoming the European Commission’s decision to allow the food sector some flexibility when making claims, EHPM said that because of concerns that the average consumer will not understand some of the scientific terminology, claims should be accompanied by further explanatory details.

“We have concerns whether the average consumer will understand scientific terminology such as ‘Homocystein metabolism’, ‘normal neurotransmission’, ‘cell division and differentiation’ and ‘sulphur amino acid metabolism’,” said EHPM Chairman Peter van Doorn. “Consumers may not interpret correctly many of the wordings listed in the annex of the draft Regulation establishing a list of permitted health claims. Therefore, it is essential that wordings can be adapted to consumer language.”

The European trade association highlighted the dual and equal requirement in the Regulation for claims to be “based on generally accepted scientific evidence” and “well understood by the average consumer”.

EHPM said that based on these requirements companies should be permitted to mention some of the specific functions and definitions cited in the European Food Safety Authority’s (EFSA) opinions, stating that this would provide consumers with valuable advice.
 
“We believe that such clarifications would greatly assist consumer understanding,” said van Doorn. “For example, a message such as ‘Pantothenic acid contributes to normal mental performance’, which relates to EFSA’s definition of mental performance as standing for those aspects of brain and nerve functions which determine aspects like concentration, learning, memory and reasoning. We hope that the European Commission and Member States take into consideration this approach with regard to flexibility.”

Related Articles

Health & Nutrition News

AstaZine Wins Novel Food Approval

28 Nov 2016 --- AstaZine Natural Astaxanthin has won Novel Food approval from the Food Safety Authority of Ireland, BGG and its subsidiary Algae Health Sciences have announced. 

Health & Nutrition News

DuPont Offer Probiotic Solutions to Consumers in South Asia

18 Nov 2016 --- For more than 30 years, DuPont Nutrition & Health has been a global leader in the science, research, and production of probiotics, and the company has recently stressed that it offers the same expertise to customers in South Asia, with a key differentiator of quality manufacturing, customization, application and regulatory support and its science substantiation.

Food Ingredients News

KEY INTERVIEW: Making the Move into Human Nutrition

14 Nov 2016 --- NutritionInsight caught up with Marc Jensen, Senior Technical Sales Representative at BIO-CAT Microbials, an innovative new player in the human probiotic sector. 

Health & Nutrition News

Nestlé Health Science Collaborate with Aimmune on Food Allergy Project

08 Nov 2016 --- Nestlé Health Science has announced that it will make an equity investment of $145 million in US-based Aimmune Therapeutics, to accelerate the development of technology designed to desensitize people with food allergies, protecting them from the consequences of accidental exposure. 

More Articles
URL : http://www.nutritioninsight.com:80/news/EU-Health-Product-Manufacturers-Call-for-Guidance-on-Flexibility-of-Claims-Wording.html